Publication Ethics & Policies

Publication Policies

The International Journal of AI EBioMedicine Innovations (IJ-AIEBI) is committed to maintaining the highest standards of academic integrity, transparency, and quality in publishing. All manuscripts submitted to the journal must comply with the following policies:

1. Peer Review Policy

  • All submissions undergo a double-blind peer review process to ensure objectivity and fairness.

  • At least two independent reviewers evaluate the manuscript for originality, scientific merit, methodology, clarity, and relevance.

  • The editorial board makes the final decision based on reviewer feedback and journal standards.

2. Open Access Policy

  • IJ-AIEBI is an open-access journal; all articles are freely available online immediately upon publication.

  • Authors retain copyright and publish under a Creative Commons license (CC BY), allowing unrestricted use, distribution, and reproduction with proper attribution.

3. Plagiarism & Originality Policy

  • Manuscripts must represent original work not published or under consideration elsewhere.

  • The journal uses plagiarism detection tools to verify originality.

  • Submissions with plagiarism, duplicate publication, or unethical practices will be rejected or retracted.

4. Ethical Compliance Policy

  • Research involving human participants, clinical trials, or animals must follow international ethical guidelines (e.g., Declaration of Helsinki).

  • Authors must provide details of institutional ethical approval and informed consent where applicable.

5. Data Sharing & Transparency

  • Authors are encouraged to make underlying data, codes, or models available for reproducibility.

  • Supplementary files may be published alongside the article to enhance transparency.

6. Conflict of Interest Policy

  • All authors, reviewers, and editors must disclose any potential conflicts of interest that could influence the research or its interpretation.

7. Retraction & Correction Policy

  • The journal reserves the right to issue corrections, retractions, or expressions of concern if research integrity is compromised.

  • Authors are responsible for correcting errors promptly upon discovery.

8. Publication Frequency

  • IJ-AIEBI publishes on a quarterly basis (four issues per year).

  • Fast-track publication is available for high-impact or time-sensitive research.

Publication Ethics

The International Journal of AI EBioMedicine Innovations (IJ-AIEBI) is committed to upholding the highest standards of publication ethics and integrity. The journal follows the guidelines of the Committee on Publication Ethics (COPE) to ensure transparency, accountability, and responsibility throughout the publication process.

Responsibilities of Authors

  • Originality: Authors must submit only original work that has not been published or submitted elsewhere.

  • Authorship: Only individuals who have made significant contributions to the research should be listed as authors. All contributors must be acknowledged appropriately.

  • Accuracy: Data and results should be reported honestly and without fabrication, falsification, or inappropriate manipulation.

  • Citations: Relevant prior work must be properly cited to acknowledge intellectual contributions.

  • Disclosure: Authors must declare any financial, professional, or personal conflicts of interest.

  • Ethical Approval: Research involving human participants, animals, or clinical data must have received prior approval from appropriate ethics committees and comply with international ethical standards.

Responsibilities of Reviewers

  • Confidentiality: Manuscripts received for review must be treated as confidential documents.

  • Objectivity: Reviews should be conducted fairly, without personal or professional bias.

  • Constructive Feedback: Reviewers should provide clear, evidence-based comments to improve the quality of manuscripts.

  • Conflict of Interest: Reviewers must decline assignments if a conflict of interest exists.

Responsibilities of Editors

  • Fair Evaluation: Editorial decisions are based solely on scholarly merit, originality, and relevance to the journal’s scope.

  • Confidentiality: Editors must keep submitted manuscripts and reviewer identities confidential.

  • Conflict of Interest: Editors should not handle manuscripts in which they have competing interests.

  • Integrity: Editors will act on cases of suspected misconduct, plagiarism, or ethical violations promptly, following COPE guidelines.

Misconduct & Malpractice

  • The journal has a zero-tolerance policy toward plagiarism, duplicate submissions, falsified data, and unethical research practices.

  • In cases of misconduct, the journal may issue corrections, retractions, or expressions of concern as necessary.